Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Carlsmed, Inc. (CARL : NSDQ)

• Company Description    Carlsmed Inc. is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions. Carlsmed Inc. is based in CARLSBAD, Calif. Number of Employees: 127

• Price / Volume Information    Yesterday's Closing Price: $15.60 Daily Weekly Monthly 20 Day Moving Average: 146,302 shares Shares Outstanding: 27.30 (millions) Market Capitalization: $425.92 (millions) Beta: 1.95 52 Week High: $17.23 52 Week Low: $8.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 13.62% 14.13% 12 Week 41.37% 38.36% Year To Date 26.32% 12.03%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1800 ASTON AVENUE SUITE 100 - CARLSBAD,CA 92008 USA ph: 760-766-1923 fax: - None http://www.carlsmed.com

• General Corporate Information    Officers Michael Cordonnier - Chief Executive Officer Leonard Greenstein - Chief Financial Officer Kevin O`Boyle - Director Niall Casey - Director Jonathan Root - Director Peer Information Carlsmed, Inc. (HLIS) Carlsmed, Inc. (AZTA) Carlsmed, Inc. (APYI) Carlsmed, Inc. (RNVA) Carlsmed, Inc. (HMSY) Carlsmed, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 14280C105 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/05/26 Share - Related Items Shares Outstanding: 27.30 Most Recent Split Date: (:1) Beta: 1.95 Market Capitalization: $425.92 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.41 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.50 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 19.90% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/05/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 5.03 Price/Cash Flow: - Price / Sales: 6.73 EPS Growth vs. Year Ago Period: 73.47% vs. Previous Quarter: -21.87% Sales Growth vs. Year Ago Period: 56.75% vs. Previous Quarter: 17.52% ROE 06/30/26 - -38.06 03/31/26 - -60.74 12/31/25 - -96.80 ROA 06/30/26 - -28.96 03/31/26 - -29.84 12/31/25 - -37.25 Current Ratio 06/30/26 - 8.84 03/31/26 - 11.88 12/31/25 - 8.87 Quick Ratio 06/30/26 - 8.66 03/31/26 - 11.67 12/31/25 - 8.74 Operating Margin 06/30/26 - -57.42 03/31/26 - -57.76 12/31/25 - -58.67 Net Margin 06/30/26 - -57.42 03/31/26 - -57.76 12/31/25 - -58.67 Pre-Tax Margin 06/30/26 - -57.42 03/31/26 - -57.76 12/31/25 - -58.67 Book Value 06/30/26 - 3.10 03/31/26 - 3.39 12/31/25 - 3.72 Inventory Turnover 06/30/26 - 7.87 03/31/26 - 8.62 12/31/25 - 11.73 Debt-to-Equity 06/30/26 - 0.18 03/31/26 - 0.17 12/31/25 - 0.16 Debt-to-Capital 06/30/26 - 15.44 03/31/26 - 14.28 12/31/25 - 13.44

Powered by Zacks Investment Research ©